Laura Holman to Double-Blind Method
This is a "connection" page, showing publications Laura Holman has written about Double-Blind Method.
Connection Strength
0.073
-
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Ann Oncol. 2024 Nov; 35(11):981-992.
Score: 0.053
-
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine. 2010 Dec 16; 29(2):304-13.
Score: 0.020